Expertise in
19
conditions

Dr. Raj Satkunasivam

Urology
Office
6560 Fannin St, 
Houston, TX 
Accepting New Patients
Offers Telehealth
Expertise in
19
conditions
Office
6560 Fannin St, 
Houston, TX 

Overview

Raj Satkunasivam is a Urologist practicing medicine in Houston, Texas.

Dr. Satkunasivam is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Cystectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 154 peer reviewed articles and participating in 3 clinical trials. Dr. Satkunasivam is currently accepting new patients.

Specialties

Urology

Licenses

Urology in TX

Hospital Affiliations

Houston Methodist Clear Lake Hospital
Houston Methodist Hospital
Houston Methodist Baytown Hospital
Houston Methodist The Woodlands Hospital
Houston Methodist Sugarland Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
6560 Fannin St, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
A Phase II Clinical Trial of Neoadjuvant Sasanlimab and Stereotactic Body Radiation Therapy as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
A Phase II Clinical Trial of Neoadjuvant Sasanlimab and Stereotactic Body Radiation Therapy as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drug: Sasanlimab
Study Phase: Phase 2
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
View 2 Less Clinical Trials

154 Total Publications

First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma.
First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma.
Journal: JAMA network open
Published: July 01, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Office

1515 Holcombe Blvd Unit 1373, 
Houston, TX 
 (0.3 miles away)
713-792-3250
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Surena Matin is a Urologist practicing medicine in Houston, Texas. Dr. Matin is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Office

1515 Holcombe Blvd Unit 1373, 
Houston, TX 
 (0.3 miles away)
713-792-3250
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jose Karam is a Urologist practicing medicine in Houston, Texas. Dr. Karam is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Reconstructive Urology Surgery.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required
1515 Holcombe Blvd, 
Houston, TX 
 (0.3 miles away)
713-792-6161
Languages Spoken:
English

Peter Black is a Urologist practicing medicine in Houston, Texas. Dr. Black is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Frequently Asked Questions about Dr. Raj Satkunasivam

How do I make an appointment with Dr. Raj Satkunasivam?

You can book an appointment with Dr. Raj Satkunasivam by calling their office at 713-441-6455. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Raj Satkunasivam a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Raj Satkunasivam is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Raj Satkunasivam specialize in?

While Dr. Raj Satkunasivam is a Urology, they have specific expertise in Bladder Cancer, Renal Cell Carcinoma (RCC), and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Raj Satkunasivam participate in research or clinical trials?

Yes. Dr. Raj Satkunasivam has published 154 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Raj Satkunasivam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Raj Satkunasivam accept my insurance?

Dr. Raj Satkunasivam accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-441-6455 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Satkunasivam's expertise for a condition
ConditionClose
    View All 12 Distinguished Conditions
    View All 7 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile